| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/12/2007 | US20070082007 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 04/12/2007 | US20070082006 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 04/12/2007 | US20070082005 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 04/12/2007 | US20070082001 Novel engineered superantigen for human therapy |
| 04/12/2007 | US20070081994 Chimeric Heteromultimer Adhesins |
| 04/12/2007 | US20070081991 Compositions and methods for modulation of immune responses |
| 04/12/2007 | US20070081987 And GD domains by determining if agent inhibits or augments heterodimerization of polypeptides; use in diagnosis of degenerative disorders (inflammatory conditions, cancer) |
| 04/12/2007 | US20070081979 Multi-functional chimeric hematopoietic receptor agonists |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | US20070081971 Non-glycosylated G-CSF capable of beneficially stabilizing G-CSF without the addition of surfactants and additives derived from human and/or animal origin; long shelf life, physiologically well-tolerated, simple to use and it is possible to dose it precisely |
| 04/12/2007 | US20070081961 Extraction and use of collagen extracted from either a sea mammal or a bony fish |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | DE112005000737T5 Mit Heparansulfat-Zuckerketten modifizierte Heparin-bindende Proteine, Verfahren zur Erzeugung derselben und Arzneimittel, welche dieselben enthalten With heparan sulfate sugar chains modified heparin-binding proteins, methods for producing the same and pharmaceutical compositions containing the same |
| 04/12/2007 | DE102005046526A1 Variante des humanen SV2A-Proteins und deren Einfluss auf die Therapieantwort bei Epilepsie Variant of the human protein SV2A and their influence on the response to therapy in epilepsy |
| 04/12/2007 | CA2854550A1 Av.beta.6 peptide ligands and their uses |
| 04/12/2007 | CA2625208A1 Production and purification of il-29 |
| 04/12/2007 | CA2624667A1 Silk proteins containing coiled coil region |
| 04/12/2007 | CA2624618A1 Av.beta.6 peptide ligands and their uses |
| 04/12/2007 | CA2624562A1 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 04/12/2007 | CA2624486A1 Novel sea lice vaccine |
| 04/12/2007 | CA2624467A1 Method of treating pancreatitis |
| 04/12/2007 | CA2624362A1 Liposomes comprising collagen and their use in improved skin care |
| 04/12/2007 | CA2624153A1 Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family |
| 04/12/2007 | CA2624131A1 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 04/12/2007 | CA2623735A1 Method for production of t cell population |
| 04/12/2007 | CA2623685A1 Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones |
| 04/12/2007 | CA2623638A1 Treatment of cancer with specific rxr agonists |
| 04/12/2007 | CA2623485A1 Rat trpm7 polynucleotide and encoded protein |
| 04/12/2007 | CA2623287A1 Interleukin-1 conjugates and uses thereof |
| 04/12/2007 | CA2623259A1 Nucleic acid molecules encoding constitutive triple response1-like polypeptides and methods of use thereof |
| 04/12/2007 | CA2623094A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | CA2623088A1 Y4 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | CA2622852A1 Tumor angiogenesis associated genes and a method for their identification |
| 04/12/2007 | CA2622772A1 Immunomodulatory compositions and uses therefor |
| 04/12/2007 | CA2622635A1 Polynucleotides of haemophilus parasuis and its use |
| 04/12/2007 | CA2622042A1 Tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi) -anchors for treatment of cancer and skin lesions |
| 04/12/2007 | CA2621326A1 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 04/12/2007 | CA2619457A1 Method of drug design |
| 04/12/2007 | CA2619053A1 Glp-1 ( glucagon-like peptide-1 ) fusion polypeptides with increased peptidase resistance |
| 04/12/2007 | CA2617544A1 Low ph aerated products |
| 04/12/2007 | CA2605781A1 Antigen binding molecules having modified fc regions and altered binding to fc receptors |
| 04/12/2007 | CA2589430A1 Torc polynucleotides and polypeptides, and methods of use |
| 04/12/2007 | CA2589422A1 Compositions and methods for inhibiting h. pylori adhesion and infection |
| 04/11/2007 | EP1772519A1 RNA binding protein and binding site useful for expression of recombinant molecules |
| 04/11/2007 | EP1772518A2 Mammalian-type glycosylation in plants |
| 04/11/2007 | EP1772516A1 Pharmaceutical compositions for the treatment of thrombosis |
| 04/11/2007 | EP1772515A1 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1772463A1 Pleckstrin-based fusion protein and method for monitoring of enzyme activities by FRET |
| 04/11/2007 | EP1771727A1 Method for the identification of a polypeptide which binds to a given pmhc complex |
| 04/11/2007 | EP1771573A2 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 04/11/2007 | EP1771569A2 Methods and compositions for modulating flowering and maturity in plants |
| 04/11/2007 | EP1771552A2 Influenza hemagglutinin and neuraminidase variants |
| 04/11/2007 | EP1771547A1 P1-35 expression units |
| 04/11/2007 | EP1771473A2 Apolipoprotein a1 mimetics and uses thereof |
| 04/11/2007 | EP1771472A1 Mutations in erbb2 associated with cancerous phenotypes |
| 04/11/2007 | EP1771471A2 Genetically modified human natural killer cell lines |
| 04/11/2007 | EP1771470A2 Actrii receptor polypeptides, methods and compositions |
| 04/11/2007 | EP1771469A1 Use of llt1 and/or cd161 for modulating the activity of cells of the immune system |
| 04/11/2007 | EP1771468A1 Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (trail) |
| 04/11/2007 | EP1771467A2 Linkers |
| 04/11/2007 | EP1771466A1 Cell cycle phase markers |
| 04/11/2007 | EP1771464A2 Improved aprotinin variants |
| 04/11/2007 | EP1771198A2 Interferon-alpha polypeptides and conjugates |
| 04/11/2007 | EP1594890B1 Peptide derived from a vca-p18 capside antigen of the epstein-barr virus and the use thereof |
| 04/11/2007 | EP1515990B1 Antagonists of cxcr3-binding cxc chemokines |
| 04/11/2007 | EP1511768B1 Immunogenic compositions |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1414953B1 Identification and cloning of the receptor gene for symbiotic nitrogen fixation |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 04/11/2007 | EP1318142B1 T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them |
| 04/11/2007 | EP1259597B1 Zinc finger domains and methods of identifying same |
| 04/11/2007 | EP1175227B1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 04/11/2007 | EP1100825B1 Human mink gene mutations associated with arrhythmia |
| 04/11/2007 | EP1054894B1 Breast cancer resistance protein (bcrp) and the dna which encodes it |
| 04/11/2007 | EP1054683B1 Modified heat shock protein-antigenic peptide complex |
| 04/11/2007 | EP1053248B1 Peptide structures and their use in diagnosis of herpes simplex virus type 2 |
| 04/11/2007 | EP1012191B1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 04/11/2007 | EP1007553B1 Zonula occludens toxin receptors |
| 04/11/2007 | EP1005492B1 Purification of von willebrand factor by cation exchanger chromatography |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0984987B1 A soluble laminin receptor precursor and methods to ihnibit its interactions |
| 04/11/2007 | EP0961780B1 Protein markers for lung cancer and use thereof |
| 04/11/2007 | EP0917585B1 Vectors for delivering viral and oncogenic inhibitors |
| 04/11/2007 | EP0755407B1 Pharmaceutical peptide formulations for treatment of dust mite allergy |
| 04/11/2007 | EP0741748B1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 04/11/2007 | EP0692031B1 Heterologous antigens in live cell vaccine strains |
| 04/11/2007 | CN1947006A Immunocompromised rodents as dual color tumor models |
| 04/11/2007 | CN1946742A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 04/11/2007 | CN1946739A Purified interleukin-15/fc fusion protein and preparation thereof |
| 04/11/2007 | CN1946738A Animal product free system and process for purifying a botulinum toxin |
| 04/11/2007 | CN1946737A Functional method for generating or screening for ligands which modulate steroid hormone receptors |
| 04/11/2007 | CN1946431A Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 04/11/2007 | CN1946430A Therapeutic agent for treatment of cancer comprising human apolipoprotein (A) kringles LK68 or LK8 genes as effective ingredient, and method for treating cancer using the same |
| 04/11/2007 | CN1946418A Treatment of conditions involving dopaminergic neuronal degeneration using NOGO receptor antagonists |
| 04/11/2007 | CN1946417A Inhibitors of type 2 vascular endothelial growth factor receptors |
| 04/11/2007 | CN1946290A Modified serum albumin with reduced affinity for nickel and copper |
| 04/11/2007 | CN1944654A Gene sequence and application of reverse transcriptive enzyme of hepatitis B virus |
| 04/11/2007 | CN1944653A DNA fragments containing gene having function relating to autonomous proliferation of plasmid |